Award-Winning Growth JPA Health just earned Med Comms Agency of the Year at the 2025 Manny Awards, signaling strong industry recognition and a proven track record that can help accelerate new business conversations with health tech, pharma and biotech clients seeking high-impact communications.

IR Practice Launch With the recent launch of an Investor Relations practice, there is a tangible opportunity to cross-sell to pharmaceutical, biotechnology and medical device companies looking to enhance IR messaging, investor outreach and capital markets communications.

M&A and Expansion Recent acquisition activity, including the integration of Akt Health, positions JPA Health as a broader global health communications partner, enabling cross-sell to clients needing integrated global PR and medical comms capabilities.

Tech-Driven Capabilities The adoption of DocsBot AI and a tech-forward toolkit (HubSpot, Meltwater, Drupal, Google Search Console) suggests a modern, data-informed approach that can be leveraged to demonstrate value in performance-driven campaigns and analytics-focused client engagements.

Financial Scale & Focus With estimated revenue in the mid-range of large independent boutique agencies and a 51-200 employee base, there are opportunities to engage mid-market health brands and emerging biotech firms seeking specialized, hands-on health communications at scale.